FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809561410> ?p ?o ?g. }

• W2809561410 endingPage "e1846" @default.
• W2809561410 startingPage "e1846" @default.
• W2809561410 abstract "A nanocrystal intravenous (IV) formulation of meloxicam is being studied with the aim of providing postoperative analgesia.This randomized, multicenter, double-blind, placebo-controlled trial evaluated meloxicam IV 30 mg or placebo (≤ 3 doses) in 219 subjects undergoing abdominoplasty. The primary endpoint was the summed pain intensity difference over 24 hours postdose (SPID24).Meloxicam IV-treated subjects had a statistically significant reduction in the least squares mean of SPID24 compared with placebo-treated subjects (-4,262.1 versus -3,535.7; P = 0.0145). Meloxicam IV was associated with statistically significant differences over placebo on several other secondary endpoints, including other SPID intervals (ie, SPID12, SPID48, and SPID24-48), achievement of perceptible pain relief, the proportion of subjects with a ≥ 30% improvement in the first 24 hours, and Patient Global Assessment of pain at hour 48. Meloxicam IV was also associated with a reduction in the number of subjects receiving opioid rescue medication during hours 24-48 and the total number of doses of opioid rescue analgesia. Meloxicam IV was generally well tolerated, with the numbers and frequencies of adverse events similar to that of the placebo group. There was no evidence of an increased risk of adverse events commonly associated with nonsteroidal anti-inflammatory drugs including bleeding, thrombotic, cardiovascular, renal, hepatic, cardiovascular, injection site, and wound healing events.Meloxicam IV provided sustained pain relief and generally was well tolerated in subjects with moderate-to-severe pain following abdominoplasty." @default.
• W2809561410 created "2018-06-29" @default.
• W2809561410 creator A5000711202 @default.
• W2809561410 creator A5004205084 @default.
• W2809561410 creator A5011641760 @default.
• W2809561410 creator A5031879487 @default.
• W2809561410 creator A5042812464 @default.
• W2809561410 creator A5047494664 @default.
• W2809561410 creator A5050058361 @default.
• W2809561410 creator A5051576326 @default.
• W2809561410 creator A5057434178 @default.
• W2809561410 creator A5075107758 @default.
• W2809561410 date "2018-06-01" @default.
• W2809561410 modified "2023-10-14" @default.
• W2809561410 title "Efficacy and Safety of Intravenous Meloxicam in Subjects with Moderate-to-severe Pain Following Abdominoplasty" @default.
• W2809561410 cites W142954314 @default.
• W2809561410 cites W1965778750 @default.
• W2809561410 cites W1978433738 @default.
• W2809561410 cites W1988145586 @default.
• W2809561410 cites W2012066745 @default.
• W2809561410 cites W2014138540 @default.
• W2809561410 cites W2017921291 @default.
• W2809561410 cites W2023633004 @default.
• W2809561410 cites W2036124616 @default.
• W2809561410 cites W2079053112 @default.
• W2809561410 cites W2257876134 @default.
• W2809561410 cites W2325220141 @default.
• W2809561410 cites W2330070213 @default.
• W2809561410 cites W2541352776 @default.
• W2809561410 cites W2583057590 @default.
• W2809561410 cites W2761456602 @default.
• W2809561410 cites W2782731897 @default.
• W2809561410 cites W2788257504 @default.
• W2809561410 cites W4211036686 @default.
• W2809561410 doi "https://doi.org/10.1097/gox.0000000000001846" @default.
• W2809561410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6157956" @default.
• W2809561410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30276064" @default.
• W2809561410 hasPublicationYear "2018" @default.
• W2809561410 type Work @default.
• W2809561410 sameAs 2809561410 @default.
• W2809561410 citedByCount "20" @default.
• W2809561410 countsByYear W28095614102018 @default.
• W2809561410 countsByYear W28095614102019 @default.
• W2809561410 countsByYear W28095614102020 @default.
• W2809561410 countsByYear W28095614102021 @default.
• W2809561410 countsByYear W28095614102022 @default.
• W2809561410 countsByYear W28095614102023 @default.
• W2809561410 crossrefType "journal-article" @default.
• W2809561410 hasAuthorship W2809561410A5000711202 @default.
• W2809561410 hasAuthorship W2809561410A5004205084 @default.
• W2809561410 hasAuthorship W2809561410A5011641760 @default.
• W2809561410 hasAuthorship W2809561410A5031879487 @default.
• W2809561410 hasAuthorship W2809561410A5042812464 @default.
• W2809561410 hasAuthorship W2809561410A5047494664 @default.
• W2809561410 hasAuthorship W2809561410A5050058361 @default.
• W2809561410 hasAuthorship W2809561410A5051576326 @default.
• W2809561410 hasAuthorship W2809561410A5057434178 @default.
• W2809561410 hasAuthorship W2809561410A5075107758 @default.
• W2809561410 hasBestOaLocation W28095614101 @default.
• W2809561410 hasConcept C126322002 @default.
• W2809561410 hasConcept C137762411 @default.
• W2809561410 hasConcept C141071460 @default.
• W2809561410 hasConcept C142724271 @default.
• W2809561410 hasConcept C168563851 @default.
• W2809561410 hasConcept C170493617 @default.
• W2809561410 hasConcept C197934379 @default.
• W2809561410 hasConcept C203092338 @default.
• W2809561410 hasConcept C204787440 @default.
• W2809561410 hasConcept C27081682 @default.
• W2809561410 hasConcept C2779751750 @default.
• W2809561410 hasConcept C2780820201 @default.
• W2809561410 hasConcept C2781063702 @default.
• W2809561410 hasConcept C2781428721 @default.
• W2809561410 hasConcept C42219234 @default.
• W2809561410 hasConcept C71924100 @default.
• W2809561410 hasConceptScore W2809561410C126322002 @default.
• W2809561410 hasConceptScore W2809561410C137762411 @default.
• W2809561410 hasConceptScore W2809561410C141071460 @default.
• W2809561410 hasConceptScore W2809561410C142724271 @default.
• W2809561410 hasConceptScore W2809561410C168563851 @default.
• W2809561410 hasConceptScore W2809561410C170493617 @default.
• W2809561410 hasConceptScore W2809561410C197934379 @default.
• W2809561410 hasConceptScore W2809561410C203092338 @default.
• W2809561410 hasConceptScore W2809561410C204787440 @default.
• W2809561410 hasConceptScore W2809561410C27081682 @default.
• W2809561410 hasConceptScore W2809561410C2779751750 @default.
• W2809561410 hasConceptScore W2809561410C2780820201 @default.
• W2809561410 hasConceptScore W2809561410C2781063702 @default.
• W2809561410 hasConceptScore W2809561410C2781428721 @default.
• W2809561410 hasConceptScore W2809561410C42219234 @default.
• W2809561410 hasConceptScore W2809561410C71924100 @default.
• W2809561410 hasIssue "6" @default.
• W2809561410 hasLocation W28095614101 @default.
• W2809561410 hasLocation W28095614102 @default.
• W2809561410 hasLocation W28095614103 @default.
• W2809561410 hasLocation W28095614104 @default.
• W2809561410 hasLocation W28095614105 @default.
• W2809561410 hasLocation W28095614106 @default.

• next